Dendritic cell-based immunotherapy: a basic review and recent advances

Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives

(2016) João Constantino et al.   Translational Research

InCVAX – A novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity

(2015) Feifan Zhou et al.   CANCER LETTERS

T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition

(2015) R. Houot et al.   Cancer Immunology Research

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant

(2014) S. Adams et al.   JOURNAL OF IMMUNOLOGY

Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

(2014) M. V. Dhodapkar et al.   Science Translational Medicine

Novel perspectives on dendritic cell-based immunotherapy of cancer

(2013) Irene Bonaccorsi et al.   IMMUNOLOGY LETTERS

At the Bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

(2013) Margaret K. Callahan et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

(2013) Paul F Robbins et al.   NATURE MEDICINE

Current Status and Future Perspectives of Dendritic Cell-Based Cancer Immunotherapy

(2013) D. H. Yi et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Dendritic Cells in Cancer Immunotherapy Clinical Trials: Are We Making Progress?

(2013) Lisa H. Butterfield   Frontiers in Immunology

Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation

(2012) Willemijn Hobo et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Optimizing Dendritic Cell-Based Immunotherapy: Tackling the Complexity of Different Arms of the Immune System

(2012) Ilse Van Brussel et al.   MEDIATORS OF INFLAMMATION

Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting

(2012) Hirokazu Matsushita et al.   NATURE

Targeting Dendritic Cells in vivo for Cancer Therapy

(2012) Irina Caminschi et al.   Frontiers in Immunology

Trial watch

(2012) Lorenzo Galluzzi et al.   OncoImmunology

Engineering Dendritic Cells to Enhance Cancer Immunotherapy

(2011) Jeanette E Boudreau et al.   MOLECULAR THERAPY

Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients

(2011) Xiaosong Li et al.   PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

Targeting human dendritic cell subsets for improved vaccines

(2011) Hideki Ueno et al.   SEMINARS IN IMMUNOLOGY

Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy

(2011) Kenichiro Hasumi et al.   Cancers

Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma

(2010) J. Rosenblatt et al.   BLOOD

Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice

(2010) Lukas W. Pfannenstiel et al.   CELLULAR IMMUNOLOGY

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

(2010) Alberto Mantovani et al.   CURRENT OPINION IN IMMUNOLOGY

Functional assessment of human dendritic cells labeled for in vivo 19F magnetic resonance imaging cell tracking

(2010) Brooke M. Helfer et al.   CYTOTHERAPY

Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies

(2010) Rebecca Klippstein et al.   Nanomedicine-Nanotechnology Biology and Medicine

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

(2009) Vedran Radojcic et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Inhibition of Transforming Growth Factor- -Mediated Immunosuppression in Tumor-Draining Lymph Nodes Augments Antitumor Responses by Various Immunologic Cell Types

(2009) T. Fujita et al.   CANCER RESEARCH

In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb

(2009) Oihana Murillo et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Immunotherapy of cancer

(2009) Hossein Borghaei et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Improving vaccines by targeting antigens to dendritic cells

(2009) Ken Shortman et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Understanding human myeloid dendritic cell subsets for the rational design of novel vaccines

(2009) Eynav Klechevsky et al.   HUMAN IMMUNOLOGY

Immune regulation by 4-1BB and 4-1BBL: complexities and challenges

(2009) Chao Wang et al.   IMMUNOLOGICAL REVIEWS

Molecular mechanism and function of CD40/CD40L engagement in the immune system

(2009) Raul Elgueta et al.   IMMUNOLOGICAL REVIEWS

Directing dendritic cell immunotherapy towards successful cancer treatment

(2009) Rachel Lubong Sabado et al.   Immunotherapy

Prolonged Survival of Dendritic Cell–Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor β-Expressing T Cells

(2009) Mercedes N. López et al.   JOURNAL OF CLINICAL ONCOLOGY

Dendritic cells and cytokines in human inflammatory and autoimmune diseases

(2008) P BLANCO et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Engineered lentivector targeting of dendritic cells for in vivo immunization

(2008) Lili Yang et al.   NATURE BIOTECHNOLOGY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE